ENDRA Life Sciences (NDRA) Current Assets (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Current Assets data on file, last reported at $536666.0 in Q1 2026.

• Current Assets for Q1 2026 came in at $536666.0, down 75.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $536666.0 (down 75.38% YoY), and the FY2025 annual result was $967969.0, down 71.81% from the prior year.
• Current Assets fell to $536666.0 in Q1 2026 per NDRA's latest filing, from $967969.0 in the prior quarter.
• Over five years, Current Assets peaked at $14.5 million in Q2 2022 and troughed at $536666.0 in Q1 2026.
• A 5-year average of $5.2 million and a median of $5.0 million in 2024 frame the typical range for Current Assets.
• On a YoY basis, Current Assets climbed as much as 71.6% in 2025 and fell as far as 78.87% in 2025.
• A 5-year view of Current Assets shows it stood at $5.4 million in 2022, then tumbled by 43.62% to $3.0 million in 2023, then climbed by 13.22% to $3.4 million in 2024, then slumped by 71.81% to $967969.0 in 2025, then slumped by 44.56% to $536666.0 in 2026.
• Business Quant data shows NDRA's Current Assets at $536666.0 in Q1 2026, $967969.0 in Q4 2025, and $1.0 million in Q3 2025.